'Method of treating or preventing neutropenia in a human patient, method of treating or preventing leukopenia in a human patient, and method of reducing the incidence of infection'

摘要

Described herein are compositions and methods for treating, preventing and ameliorating diseases and conditions characterized by a lower than normal white blood cell count, such as leukopenia and neutropenia. The compositions and methods include recombinant human albumin-human granulocyte colony stimulating factor. Pharmaceutical formulations including the recombinant fusion protein, and methods of making such formulations are also described.